IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc. (IXHL) is expected to report earnings on August 27, 2026, after the market close. The consensus earnings estimate is $0.13 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -14.8% since its last earnings release on May 15, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Incannex Healthcare Inc.
Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.
Sector
Healthcare
Industry
Biotechnology